tiprankstipranks
Trending News
More News >
Atossa Therapeutics, Inc. (GB:0HJ7)
:0HJ7
UK Market

Atossa Therapeutics (0HJ7) Income Statement

Compare
0 Followers

Atossa Therapeutics Income Statement

Last quarter (Q1 2025), Atossa Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Atossa Therapeutics's net income was $-6.72M. See Atossa Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -17.00K$ -23.00K$ -8.00K$ -23.00K$ -46.60K
Operating Expenses
$ 27.60M$ 31.38M$ 27.69M$ 20.52M$ 14.61M
Depreciation and Amortization
$ 17.00K$ 23.00K$ 8.00K$ 23.00K$ 46.60K
EBITDA
$ -25.49M$ -31.35M$ -27.68M$ -20.50M$ -14.56M
Operating Income
$ -27.62M$ -31.38M$ -27.69M$ -20.52M$ -14.61M
Other Income/Expenses
$ 2.12M$ 1.28M$ 731.00K$ -85.00K$ -3.22M
Pretax Income
$ -25.50M$ -30.09M$ -26.96M$ -20.61M$ -17.83M
Net Income
$ -25.50M$ -30.09M$ -26.23M$ -20.61M$ -21.10M
Per Share Metrics
Basic EPS
$ -0.20$ -0.24$ -0.21$ -0.18$ -1.87
Diluted EPS
$ -0.20$ -0.24$ -0.21$ -0.18$ -1.87
Weighted Average Shares Outstanding
125.86M 126.08M 126.62M 116.95M 11.31M
Weighted Average Shares Outstanding (Diluted)
125.86M 126.08M 126.62M 116.95M 11.31M
Currency in USD

Atossa Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis